健康计划事先授权对临床疗效和患者预后的不良影响:一项系统综述。

IF 5.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Jacob Murphy, Norman Beauchamp, Kristi J Sun, Brandyn D Lau, Renee F Wilson, Katie Lobner, Sarah J Conway, Peter M Hill, Pamela T Johnson
{"title":"健康计划事先授权对临床疗效和患者预后的不良影响:一项系统综述。","authors":"Jacob Murphy, Norman Beauchamp, Kristi J Sun, Brandyn D Lau, Renee F Wilson, Katie Lobner, Sarah J Conway, Peter M Hill, Pamela T Johnson","doi":"10.1016/j.amjmed.2025.08.018","DOIUrl":null,"url":null,"abstract":"<p><p>Prior authorization requirements by health insurance plans have become a barrier to healthcare delivery in the United States in terms of clinical efficiency, patient and provider experience. Surveyed physicians report associations with care delays, reduced clinical effectiveness and compromised patient outcomes. In this systematic review, we synthesized the published evidence regarding harmful effects of prior authorization on disease management and patient outcomes. Twenty-five studies were included. In addition to care delays, authorization requirements were associated with disease exacerbation, preventable hospitalization, prolonged hospital stay, and lower rates of disease-free survival. Studies spanned multiple specialties including oncology, cardiology, behavioral health and pediatrics. Published evidence shows that prior authorization requirements are associated with measurable patient harm across multiple healthcare domains. Recognizing that a small number of retrospective studies do not adequately quantify the harm, we propose establishing national quality metrics for health plans, using claims data to track longitudinal outcomes in patients subject to delays and denials.</p>","PeriodicalId":50807,"journal":{"name":"American Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adverse Effects of Health Plan Prior Authorization on Clinical Effectiveness and Patient Outcomes: A Systematic Review.\",\"authors\":\"Jacob Murphy, Norman Beauchamp, Kristi J Sun, Brandyn D Lau, Renee F Wilson, Katie Lobner, Sarah J Conway, Peter M Hill, Pamela T Johnson\",\"doi\":\"10.1016/j.amjmed.2025.08.018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Prior authorization requirements by health insurance plans have become a barrier to healthcare delivery in the United States in terms of clinical efficiency, patient and provider experience. Surveyed physicians report associations with care delays, reduced clinical effectiveness and compromised patient outcomes. In this systematic review, we synthesized the published evidence regarding harmful effects of prior authorization on disease management and patient outcomes. Twenty-five studies were included. In addition to care delays, authorization requirements were associated with disease exacerbation, preventable hospitalization, prolonged hospital stay, and lower rates of disease-free survival. Studies spanned multiple specialties including oncology, cardiology, behavioral health and pediatrics. Published evidence shows that prior authorization requirements are associated with measurable patient harm across multiple healthcare domains. Recognizing that a small number of retrospective studies do not adequately quantify the harm, we propose establishing national quality metrics for health plans, using claims data to track longitudinal outcomes in patients subject to delays and denials.</p>\",\"PeriodicalId\":50807,\"journal\":{\"name\":\"American Journal of Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2025-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.amjmed.2025.08.018\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amjmed.2025.08.018","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

就临床效率、患者和提供者经验而言,健康保险计划的事先授权要求已成为美国医疗保健服务的障碍。接受调查的医生报告与护理延误、临床疗效降低和患者预后受损有关。在这篇系统综述中,我们综合了关于事先授权对疾病管理和患者预后的有害影响的已发表证据。纳入了25项研究。除了护理延误外,授权要求还与疾病恶化、可预防的住院、延长住院时间和较低的无病生存率有关。研究涉及多个专业,包括肿瘤学、心脏病学、行为健康和儿科。公开的证据表明,事先授权要求与多个医疗保健领域中可衡量的患者伤害相关。认识到少数回顾性研究不能充分量化危害,我们建议为健康计划建立国家质量指标,使用索赔数据跟踪延迟和拒绝的患者的纵向结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Adverse Effects of Health Plan Prior Authorization on Clinical Effectiveness and Patient Outcomes: A Systematic Review.

Prior authorization requirements by health insurance plans have become a barrier to healthcare delivery in the United States in terms of clinical efficiency, patient and provider experience. Surveyed physicians report associations with care delays, reduced clinical effectiveness and compromised patient outcomes. In this systematic review, we synthesized the published evidence regarding harmful effects of prior authorization on disease management and patient outcomes. Twenty-five studies were included. In addition to care delays, authorization requirements were associated with disease exacerbation, preventable hospitalization, prolonged hospital stay, and lower rates of disease-free survival. Studies spanned multiple specialties including oncology, cardiology, behavioral health and pediatrics. Published evidence shows that prior authorization requirements are associated with measurable patient harm across multiple healthcare domains. Recognizing that a small number of retrospective studies do not adequately quantify the harm, we propose establishing national quality metrics for health plans, using claims data to track longitudinal outcomes in patients subject to delays and denials.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
American Journal of Medicine
American Journal of Medicine 医学-医学:内科
CiteScore
6.30
自引率
3.40%
发文量
449
审稿时长
9 days
期刊介绍: The American Journal of Medicine - "The Green Journal" - publishes original clinical research of interest to physicians in internal medicine, both in academia and community-based practice. AJM is the official journal of the Alliance for Academic Internal Medicine, a prestigious group comprising internal medicine department chairs at more than 125 medical schools across the U.S. Each issue carries useful reviews as well as seminal articles of immediate interest to the practicing physician, including peer-reviewed, original scientific studies that have direct clinical significance and position papers on health care issues, medical education, and public policy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信